-
Study aim
-
Evaluation of efficacy of low-fat dairy products fortified with Nano-encapsulated vitamin D on biochemical markers in adults aged 18 to 65 in Mashhad
-
Design
-
The parallel, double-blinded, and randomised phase 3 clinical trial including control group was conducted on 280 adults.
-
Settings and conduct
-
The study is a randomized, double-blind clinical trial (therapist and patient are not aware about type of medicine). fortified low-fat dairy products, containing encapsulated vitamin D (1500IU), will be prepared in reliable dairy factory. 280 adlults, who lived in Mashhad, will participate in the trial. In this project, individuals are randomly divided into 2 control group and 2 intervention groups. All of the groups complete general information questionnair including demographic information, history of any diseases, and current treatments before starting the trial. ٍEach control group receive one non-fortified dairy product (milk or yogurt) and in each intervention group, one of the products (milk or yogurt) is fortified with vitamin D. Intervention will be considered for 2.5 months.
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria inculded aged between 18 to 65; having consent for participation in study
Exclusion criteria inculded Not taking any vitamin D supplements three months before the study; not having Chronic Liver Diseases, Cystic Fibrosis, Crohn's, and Sprue
-
Intervention groups
-
Control group receiving non-fortified milk.
Intervention group receiving daily milk which is fortified with encapsulated vitamin D (1500 IU).
Control group receiving non-fortified yogurt.
Intervention group receiving daily yogurt which is fortified with encapsulated vitamin D (1500 IU).
-
Main outcome variables
-
Bone density, anthropometric factors, blood pressure, biochemical state, depression, eating habits